OpenURL Connection Search

Select item for more details and to access through your institution.

Characterization of the rebinding of <sup>125</sup>I-epidermal growth factor released from BALB/c-3T3 cells following accumulation in the presence of chloroquine.
Published in:
Journal of Cellular Physiology, 1988, v. 134, n. 3, p. 387, doi. 10.1002/jcp.1041340309
By:
- Cooper, Janet L.;
- Wakshull, Eric;
- Wharton, Walker
Publication type:
Article
Preexisting Antibodies to an F(ab')2 Antibody Therapeutic and Novel Method for Immunogenicity Assessment.
Published in:
2016
By:
- Ruppel, Jane;
- Brady, Ann;
- Elliott, Rebecca;
- Leddy, Cecilia;
- Palencia, Marco;
- Coleman, Daniel;
- Couch, Jessica A.;
- Wakshull, Eric
Publication type:
journal article
Advancements in Understanding Immunogenicity of Biotherapeutics in the Intraocular Space.
Published in:
AAPS Journal, 2017, v. 19, n. 6, p. 1656, doi. 10.1208/s12248-017-0128-y
By:
- Wakshull, Eric;
- Quarmby, Valerie;
- Mahler, Hanns-Christian;
- Rivers, Hongwen;
- Jere, Dhananjay;
- Ramos, Meg;
- Szczesny, Piotr;
- Bechtold-Peters, Karoline;
- Masli, Sharmila;
- Gupta, Swati
Publication type:
Article
Workshop Report: AAPS Workshop on Method Development, Validation, and Troubleshooting of Ligand-Binding Assays in the Regulated Environment.
Published in:
2015
By:
- Kelley, Marian;
- Stevenson, Lauren;
- Golob, Michaela;
- Devanarayan, Viswanath;
- Pedras-Vasconcelos, Joao;
- Staack, Roland;
- Jenkins, Rand;
- Booth, Brian;
- Wakshull, Eric;
- Bowsher, Ronald;
- Rock, Marie;
- Dudal, Sherri;
- DeSilva, Binodh
Publication type:
Report
Activation of a Rel-A/CEBP-β-related transcription factor heteromer by PGG-Glucan in a murine monocytic cell line.
Published in:
Journal of Cellular Biochemistry, 2000, v. 77, n. 2, p. 221, doi. 10.1002/(SICI)1097-4644(20000501)77:2<221::AID-JCB6>3.0.CO;2-V
By:
- Adams, David S.;
- Nathans, Robin;
- Pero, Stephanie C.;
- Sen, Ami;
- Wakshull, Eric
Publication type:
Article
Receptor-mediated phagocytosis of rat macrophages is regulated differentially for opsonized particles and non-opsonized particles containing β-glucan.
Published in:
Immunology, 2001, v. 104, n. 2, p. 198, doi. 10.1046/j.1365-2567.2001.01291.x
By:
- Reichner, Jonathan S.;
- Fitzpatrick, Paul A.;
- Wakshull, Eric;
- Albina, Jorge E.
Publication type:
Article
Phase I study of the anti-α5β1 monoclonal antibody MINT1526A with or without bevacizumab in patients with advanced solid tumors.
Published in:
2018
By:
- Weekes, Colin D.;
- Rosen, Lee S.;
- Capasso, Anna;
- Wong, Kit Man;
- Ye, Weilan;
- Anderson, Maria;
- McCall, Bruce;
- Fredrickson, Jill;
- Wakshull, Eric;
- Eppler, Steve;
- Shon-Nguyen, Quyen;
- Desai, Rupal;
- Huseni, Mahrukh;
- Hegde, Priti S.;
- Pourmohamad, Tony;
- Rhee, Ina;
- Bessudo, Alberto
Publication type:
journal article
Randomized Phase II Trial of Parsatuzumab (Anti‐EGFL7) or Placebo in Combination with Carboplatin, Paclitaxel, and Bevacizumab for First‐Line Nonsquamous Non‐Small Cell Lung Cancer.
Published in:
Oncologist, 2018, v. 23, n. 6, p. 654, doi. 10.1634/theoncologist.2017-0690
By:
- von Pawel, Joachim;
- Spigel, David R.;
- Ervin, Thomas;
- Losonczy, György;
- Barlesi, Fabrice;
- Juhász, Erzsébet;
- Anderson, Maria;
- McCall, Bruce;
- Wakshull, Eric;
- Hegde, Priti;
- Ye, Weilan;
- Chen, Daniel;
- Chang, Ilsung;
- Rhee, Ina;
- Reck, Martin
Publication type:
Article
Randomized Phase II Trial of Parsatuzumab (Anti-EGFL7) or Placebo in Combination with FOLFOX and Bevacizumab for First-Line Metastatic Colorectal Cancer.
Published in:
Oncologist, 2017, v. 22, n. 4, p. 375, doi. 10.1634/theoncologist.2016-0133
By:
- García‐Carbonero, Rocío;
- van Cutsem, Eric;
- Rivera, Fernando;
- Jassem, Jacek;
- Gore, Ira;
- Tebbutt, Niall;
- Braiteh, Fadi;
- Argiles, Guillem;
- Wainberg, Zev A.;
- Funke, Roel;
- Anderson, Maria;
- McCall, Bruce;
- Stroh, Mark;
- Wakshull, Eric;
- Hegde, Priti;
- Ye, Weilan;
- Chen, Daniel;
- Chang, Ilsung;
- Rhee, Ina;
- Hurwitz, Herbert
Publication type:
Article

Found: 9